Switch theme
Sign up to access all valuation multiples
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
1999
39.3K+
LTM Revenue $4.5B
LTM EBITDA $521M
$10.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Ensign Group has a last 12-month revenue (LTM) of $4.5B and a last 12-month EBITDA of $521M.
In the most recent fiscal year, Ensign Group achieved revenue of $4.3B and an EBITDA of $479M.
Ensign Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Ensign Group valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $4.5B | XXX | $4.3B | XXX | XXX | XXX |
| Gross Profit | $959M | XXX | $668M | XXX | XXX | XXX |
| Gross Margin | 21% | XXX | 16% | XXX | XXX | XXX |
| EBITDA | $521M | XXX | $479M | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| EBIT | $438M | XXX | $358M | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 8% | XXX | XXX | XXX |
| Net Profit | $342M | XXX | $298M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 7% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Ensign Group's stock price is $147.
Ensign Group has current market cap of $8.5B, and EV of $10.1B.
See Ensign Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $10.1B | $8.5B | XXX | XXX | XXX | XXX | $5.83 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Ensign Group has market cap of $8.5B and EV of $10.1B.
Ensign Group's trades at 2.4x EV/Revenue multiple, and 21.2x EV/EBITDA.
Equity research analysts estimate Ensign Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Ensign Group has a P/E ratio of 24.8x.
See valuation multiples for Ensign Group and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $8.5B | XXX | $8.5B | XXX | XXX | XXX |
| EV (current) | $10.1B | XXX | $10.1B | XXX | XXX | XXX |
| EV/Revenue | 2.2x | XXX | 2.4x | XXX | XXX | XXX |
| EV/EBITDA | 19.4x | XXX | 21.2x | XXX | XXX | XXX |
| EV/EBIT | 23.1x | XXX | 28.3x | XXX | XXX | XXX |
| EV/Gross Profit | 10.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | 24.8x | XXX | 28.4x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 53.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialEnsign Group's last 12 month revenue growth is 13%
Ensign Group's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $8K for the same period.
Ensign Group's rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ensign Group's rule of X is 44% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Ensign Group and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Growth | 14% | XXX | 27% | XXX | XXX | XXX |
| Rule of 40 | 22% | XXX | 24% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 44% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $8K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 7% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| National Healthcare Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Regis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Addus HomeCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Amedisys | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ensign Group acquired XXX companies to date.
Last acquisition by Ensign Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Ensign Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Ensign Group founded? | Ensign Group was founded in 1999. |
| Where is Ensign Group headquartered? | Ensign Group is headquartered in United States of America. |
| How many employees does Ensign Group have? | As of today, Ensign Group has 39.3K+ employees. |
| Who is the CEO of Ensign Group? | Ensign Group's CEO is Mr. Barry R. Port. |
| Is Ensign Group publicy listed? | Yes, Ensign Group is a public company listed on NAS. |
| What is the stock symbol of Ensign Group? | Ensign Group trades under ENSG ticker. |
| When did Ensign Group go public? | Ensign Group went public in 2007. |
| Who are competitors of Ensign Group? | Similar companies to Ensign Group include e.g. National Healthcare Corp, Regis Healthcare, Maternus-Kliniken, Addus HomeCare. |
| What is the current market cap of Ensign Group? | Ensign Group's current market cap is $8.5B |
| What is the current revenue of Ensign Group? | Ensign Group's last 12 months revenue is $4.5B. |
| What is the current revenue growth of Ensign Group? | Ensign Group revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of Ensign Group? | Current revenue multiple of Ensign Group is 2.2x. |
| Is Ensign Group profitable? | Yes, Ensign Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Ensign Group? | Ensign Group's last 12 months EBITDA is $521M. |
| What is Ensign Group's EBITDA margin? | Ensign Group's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of Ensign Group? | Current EBITDA multiple of Ensign Group is 19.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
